News

AstraZeneca boost as EU approves cancer drug
It comes amid reports that the drugs maker is considering moving its listing from the UK to the US in what would be a hammer ...
AstraZeneca exit: here’s what it really means for the UK
AstraZeneca Plc (LON: AZN) is in focus this morning following reports that its chief executive – Pascal Soriot is considering ...
LondonLovesBusiness1d
Reeves hit with another blow as AstraZeneca considering leaving the UK
The biopharmaceutical giant AstraZeneca is considering moving their stock listing from the London Stock Exchange to the US in ...
London stock market could weather its biggest blow yet if AstraZeneca exits
The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...
Share Prices15h
LONDON BRIEFING: AstraZeneca wins EU nod for bladder cancer therapy
In early corporate news, AstraZeneca receives EU approval for a bladder cancer therapy, and a subdued housing market leaves MJ Gleeson eyeing adjusted pretax profit at the lower end of current market ...
AstraZeneca CEO Wants to Move Listing to US, Times Reports
AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...
Summit, AstraZeneca in Talks Over $15 Billion Cancer Drug Licensing Deal, Bloomberg News Reports
(Reuters) -AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as ...
AstraZeneca boss mulls New York listing in fresh blow for City: Exodus risks transforming London into a 'global backwater'
AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...
London IPOs Hit 28-Year Low Amid AstraZeneca Exit Concerns
London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...